z-logo
Premium
Structure and inhibition of N ‐acetylneuraminate lyase from methicillin‐resistant Staphylococcus aureus
Author(s) -
North Rachel A.,
Watson Andrew J. A.,
Pearce F. Grant,
MuscroftTaylor Andrew C.,
Friemann Rosmarie,
Fairbanks Antony J.,
Dobson Renwick C. J.
Publication year - 2016
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1002/1873-3468.12462
Subject(s) - lyase , enzyme , sialic acid , chemistry , staphylococcus aureus , catabolism , biochemistry , microbiology and biotechnology , clostridium perfringens , ligand (biochemistry) , bacteria , biology , receptor , genetics
N ‐Acetylneuraminate lyase is the first committed enzyme in the degradation of sialic acid by bacterial pathogens. In this study, we analyzed the kinetic parameters of N ‐acetylneuraminate lyase from methicillin‐resistant Staphylococcus aureus ( MRSA ). We determined that the enzyme has a relatively high K M of 3.2 m m , suggesting that flux through the catabolic pathway is likely to be controlled by this enzyme. Our data indicate that sialic acid alditol, a known inhibitor of N ‐acetylneuraminate lyase enzymes, is a stronger inhibitor of MRSA N ‐acetylneuraminate lyase than of Clostridium perfringens N ‐acetylneuraminate lyase. Our analysis of the crystal structure of ligand‐free and 2 R ‐sialic acid alditol‐bound MRSA N ‐acetylneuraminate lyase suggests that subtle dynamic differences in solution and/or altered binding interactions within the active site may account for species‐specific inhibition.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom